Efficacy and Safety of Deferasirox (Exjade®) in Patients with β-Thalassemia Major Treated for up to 5 Years

被引:0
|
作者
Cappellini, M. Domenica [1 ]
Perrotta, Silverio [2 ]
Agaoglu, Leyla [3 ]
Aydinok, Yesim [4 ]
Capra, Marcello [5 ]
Canatan, Duran [6 ]
Drelichman, Guillermo [7 ]
Kilinc, Yurdanur [8 ]
Magnano, Carmelo [9 ]
Porter, John B. [10 ]
Piga, Antonio [11 ]
Griffel, Louis [12 ]
Lagrone, Darlene [12 ]
Clark, Joan [13 ]
Kattamis, Antonis [14 ]
机构
[1] Univ Milan, Fdn IRCCS Osped Maggiore Policlin Mangiagalli & R, Milan, Italy
[2] I Policlin II Univ Napoli, Naples, Italy
[3] Istanbul Univ, Istanbul Sch Med, Div Pediat Hematol Oncol, Istanbul, Turkey
[4] Ege Univ, Fac Med, Izmir, Turkey
[5] Osped Civ & Benefratelli G Di Cristina M Ascoli, Palermo, Italy
[6] Suleyman Demirel Univ, Fac Med, TR-32200 Isparta, Turkey
[7] Hosp Ninos Dr Ricardo Gutierrez, Buenos Aires, DF, Argentina
[8] Cukurova Univ, Fac Med, Dept Pediat Hem Onc, Adana, Turkey
[9] Az Osped Riliervo Nazl & Alta Spec Garibaldi, Catania, Italy
[10] UCL, London, England
[11] Univ Turin, Turin, Italy
[12] Novartis Pharmaceut, E Hanover, NJ USA
[13] Novartis Pharma AG, Basel, Switzerland
[14] Univ Athens, Dept Pediat 1, Athens, Greece
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1558 / 1559
页数:2
相关论文
共 50 条
  • [41] Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial
    Kremer, J. M.
    Blanco, R.
    Halland, A. -M.
    Brzosko, M.
    Burgos-Vargas, R.
    Mela, C. M.
    Rowell, L.
    Fleischman, R. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 625 - 633
  • [42] Iron chelating efficacy is related to transfusional iron intake in pediatric patients-treated with deferasirox(Exjade®, ICL670)
    Kattarruis, A.
    Paley, C.
    PEDIATRIC BLOOD & CANCER, 2007, 48 (06) : 609 - 609
  • [43] DEFERASIROX IMPROVES LIVER FIBROSIS IN. THALASSAEMIA MAJOR PATIENTS. A 5 YEARS FOLLOW UP STUDY
    Vlachaki, E.
    Sinakos, E.
    Adamidou, D.
    Gigi, E.
    Chologitas, E.
    Panteliadou, A. -K.
    Klonizakis, F.
    Mandala, E.
    HAEMATOLOGICA, 2015, 100 : 592 - 592
  • [44] SAFETY AND EFFICACY OF 4 YEARS OF DEFERASIROX TREATMENT FOR SICKLE CELL DISEASE PATIENTS
    Vlachaki, Efthymia
    Mainou, Maria
    Bekiari, Eleni
    Vetsiou, Evaggelia
    Tsapas, Apostolos
    HEMOGLOBIN, 2013, 37 (01) : 94 - 100
  • [45] A COMPARISON OF NOVEL SERUM MARKERS FOR THE ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH BETA THALASSEMIA MAJOR TREATED WITH DEFERASIROX
    Aydinok, Y.
    Arikan, C.
    Karakas, Z.
    Sasmaz, I.
    Canatan, D.
    Agaoglu, L.
    Kilinc, Y.
    Canatar, A.
    Ocak, O.
    Alnigenis, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 718 - 718
  • [46] Efficacy and safety of deferasirox (Exjade®) in chelation-naive and previously chelated patients with transfusion-dependent myelodysplastic syndromes (MDS)
    Schmid, M.
    Guerci-Bresler, A.
    Della Porta, M.
    Taylor, K.
    Habr, D.
    Domokos, G.
    Roubert, B.
    Rose, C.
    Gattermann, N.
    LEUKEMIA RESEARCH, 2009, 33 : S141 - S142
  • [47] Comparison of contrast sensitivity in β-thalassemia patients treated by deferoxamine or deferasirox
    Ghazanfari, Azam
    Jafarzadehpour, Ebrahim
    Heydarian, Samira
    Dailami, Kiumars Nowroozpoor
    Karami, Hosein
    JOURNAL OF OPTOMETRY, 2019, 12 (03) : 168 - 173
  • [48] EFFICACY AND SAFETY OF DEFERASIROX IN REDUCING MYOCARDIAL SIDEROSIS IN PATIENTS WITH B-THALASSAEMIA MAJOR
    Pennell, D.
    Porter, J. B.
    Cappellini, M. D.
    Chan, L. L.
    El-Beshlawy, A.
    Aydinok, Y.
    Ibrahim, H.
    Li, C. -K.
    Viprakasit, V.
    Elalfy, M.
    Kattamis, A.
    Smith, G.
    Habr, D.
    Domokos, G.
    Hmissi, A.
    Taher, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 74 - 75
  • [49] Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years
    Korn, Stephanie
    Bourdin, Arnaud
    Chupp, Geoffrey
    Cosio, Borja G.
    Arbetter, Doug
    Shah, Mihir
    Garcia Gil, Esther
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (12): : 4381 - +
  • [50] Safety and efficacy of deferasirox in multitransfused Indian children with β-thalassaemia major
    Chandra, J.
    Chaudhary, H.
    Pemde, H.
    Singh, V.
    Dutta, A. K.
    ANNALS OF TROPICAL PAEDIATRICS, 2011, 31 (01): : 47 - 51